Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127166851 | 12716685 | 1 | I | 20160728 | 20160829 | 20160906 | 20160906 | EXP | FR-PFIZER INC-2016416359 | PFIZER | 32.00 | YR | M | Y | 0.00000 | 20160906 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127166851 | 12716685 | 1 | PS | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | Oral | UNK | Y | 20987 | |||||||||
| 127166851 | 12716685 | 2 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | UNK | Y | 77908 | EMULSION FOR INJECTION | ||||||||
| 127166851 | 12716685 | 3 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | UNK | Y | 0 | SOLUTION FOR INJECTION | ||||||||
| 127166851 | 12716685 | 4 | SS | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 5 | SS | PERFALGAN | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 6 | SS | SUFENTANIL | SUFENTANIL | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 7 | SS | PROFENID | KETOPROFEN | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 8 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 9 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous (not otherwise specified) | 2 G, ONE SINGLE | Y | 0 | 2 | G | |||||||
| 127166851 | 12716685 | 10 | SS | NIMBEX | CISATRACURIUM BESYLATE | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 127166851 | 12716685 | 11 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127166851 | 12716685 | 1 | Gastrooesophageal reflux disease |
| 127166851 | 12716685 | 2 | Induction of anaesthesia |
| 127166851 | 12716685 | 3 | Thrombosis prophylaxis |
| 127166851 | 12716685 | 4 | Pain |
| 127166851 | 12716685 | 5 | Pain |
| 127166851 | 12716685 | 6 | Induction of anaesthesia |
| 127166851 | 12716685 | 7 | Pain |
| 127166851 | 12716685 | 8 | Pain |
| 127166851 | 12716685 | 9 | Antibiotic prophylaxis |
| 127166851 | 12716685 | 10 | Induction of anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127166851 | 12716685 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127166851 | 12716685 | Erythema | |
| 127166851 | 12716685 | Purpura | |
| 127166851 | 12716685 | Rash pustular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127166851 | 12716685 | 1 | 20160726 | 20160801 | 0 | |
| 127166851 | 12716685 | 2 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 3 | 20160727 | 20160801 | 0 | |
| 127166851 | 12716685 | 4 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 5 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 6 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 7 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 8 | 20160727 | 20160801 | 0 | |
| 127166851 | 12716685 | 9 | 20160727 | 20160727 | 0 | |
| 127166851 | 12716685 | 10 | 20160727 | 20160727 | 0 |